Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 4

Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol

Total article views   HTML views PDF downloads Totals
5,707 Dovepress* 5,707+ 2,067 7,774
Totals 5,707 2,067 7,774
*Since 15 September 2007
+Since July 2016

View citations on Google Scholar